CAS: 954126-98-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | DANIRIXIN REF: AN-AG01DGJ4CAS: 954126-98-8 | 98+% | 90.00 €~471.00 € | Thu 23 May 24 |
 | Danirixin REF: TM-T5193CAS: 954126-98-8 | 99.78% | 86.00 €~2,166.00 € | Thu 30 May 24 |
 | Danirixin (GSK1325756) REF: 4Z-K-031085CAS: 954126-98-8 | - - - | To inquire | Thu 30 May 24 |
 | Danirixin (GSK1325756) REF: 3D-ENB12698CAS: 954126-98-8 | Min. 95% | To inquire | Fri 05 Jul 24 |
DANIRIXIN
CAS:954126-98-8
Formula:
C19H21ClFN3O4S
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
441.9041
Ref: AN-AG01DGJ4
| 5mg | 90.00 € | |
| 10mg | 124.00 € | |
| 25mg | 175.00 € | |
| 50mg | 295.00 € | |
| 100mg | 471.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Danirixin
CAS:954126-98-8
Danirixin (GSK1325756) is a potent antagonist of CXCR2 that inhibits IL-8 binding to CXCR2 (IC50: …
Formula:
C19H21ClFN3O4S
Purity:
99.78%
Color and Shape:
Solid
Molecular weight:
441.9
Ref: TM-T5193
| 1mg | 86.00 € | |
| 5mg | 231.00 € | |
| 10mg | 324.00 € | |
| 25mg | 546.00 € | |
| 50mg | 782.00 € | |
| 100mg | 1,082.00 € | |
| 500mg | 2,166.00 € | |
| 1ml*10 (DMSO) | 259.00 € |
Estimated delivery in United States, on Thursday 30 May 2024
Ref: 4Z-K-031085
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 30 May 2024
Danirixin (GSK1325756)
CAS:954126-98-8
Danirixin is a small molecule drug that has been shown to inhibit the activity of …
Formula:
C19H21ClFN3O4S
Purity:
Min. 95%
Molecular weight:
441.9 g/mol
Ref: 3D-ENB12698
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 5 Jul 2024
